secwatch.observer — SEC 8-K summary
======================================

Issuer:     iBio, Inc. (IBIO)
CIK:        0001420720
Form:       8-K
Filed at:   2024-07-09T23:59:59+00:00
Accession:  0001420720-24-000029
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02, 5.05, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

iBio adopts standard equity award forms and updates Code of Business Conduct
----------------------------------------------------------------------------

- Board approved forms of stock option and RSU agreements for directors, officers, employees, and consultants under the 2023 Plan.
- Award agreements include provisions for exercise price payment methods, vesting schedules, and termination treatment.
- Updated Code of Business Conduct and Ethics to modernize language and enhance risk mitigation.
- No executive departures, new appointments, or financial guidance changes were disclosed.
- Actions are routine governance updates with no immediate material financial impact.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420720/000142072024000029/0001420720-24-000029-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420720/000142072024000029/ibio-20240702x8k.htm
  HTML page:      https://secwatch.observer/filing/0001420720-24-000029

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer